SOMERSET, N.J.,– May 26, 2009? inVentiv Clinical Solutions, LLC (“inVentiv Clinical”), a division of inVentiv Health (NASDAQ: VTIV), today announced the promotion of Scott Treiber, PhD, formerly Senior Vice President, Clinical Operations, to Executive Vice President, Clinical Development Solutions.
In his new role, Dr. Treiber will be responsible for leading the Contract Research Organization Services (CROS) group and facilitating the interaction between clinical service groups. He will oversee all aspects of clinical management and ensure clients are provided with a variety of flexible options to meet their clinical objectives.
“Scott has provided exceptional leadership since joining the company last June,” said Mike Hlinak, President and Chief Executive Officer of inVentiv Clinical Solutions. “His clinical knowledge and previous experience in the contract research industry has significantly contributed to our growth over the past year. I’m very pleased he is taking a larger role as part of our executive management team.”
Dr. Treiber has more than 20 years of experience in clinical and medical research industries with a compelling background in delivering contract research services to pharmaceutical and biotechnology clients. Prior to joining inVentiv, Dr. Treiber served as Vice President, Clinical Research for PharmaNet, with overall responsibility for the Neuroscience, Cardiovascular/General Medicine, Ophthalmology and Dermatology therapeutic divisions. Dr. Treiber received his PhD in Biology from the University of California at Santa Cruz and his MBA from Ellis College of the New York Institute of Technology.
About inVentiv Clinical Solutions
inVentiv Clinical Solutions is the premier provider of unique clinical outsourcing solutions, allowing the greatest control and flexibility through unmatched access to high quality clinical resources. As a strategic partner, inVentiv Clinical Solutions provides clinical trial management and monitoring, data management and biostatistics solutions, medical writing, regulatory consulting and liaison services and patient and investigator recruitment. These services are complemented by traditional clinical staffing capabilities through our industry leading staffing divisions, MedFocus and Smith Hanley Consulting Group. For more information, visit http://www.inventivclinical.com/.
About inVentiv Health
inVentiv Health, Inc. (NASDAQ: VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health’s client roster is comprised of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit www.inventivhealth.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health’s performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
